MMedication Read More Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders14 May 2026 Novo Nordisk has shared new data that suggests a higher dose version of its blockbuster weight loss drug,…
MMedication Read More A Common Migraine Medication May Lower Glaucoma Risk By 25%14 May 2026 The strongest association was seen with monoclonal antibody CGRP inhibitors, a category that includes medications, including Erenumab and…
MMedication Read More DoxyPEP Effectiveness Against Gonorrhea Is Declining13 May 2026 DoxyPEP is becoming less effective against gonorrhea as antibiotic resistance rises, even as protection against chlamydia and syphilis…
MMedication Read More Exact weight to qualify for free weight loss jabs as switch to new pill could maintain 80% of fat loss13 May 2026 You could qualify for free GLP-1 medication, but there are particular criteria that you have to meet. GLP-1…
MMedication Read More Patchouli oil shows surprising power against mosquitoes13 May 2026 Patchouli oil is the scent people either love or leave the room to escape. It clings to incense…
MMedication Read More Cheaper generic Ozempic is coming soon — but not for Americans. Here’s why.13 May 2026 India got it earlier this year, and Canada approved it last month. But when is the United States…
MMedication Read More Over 32,000 unapproved pills headed to Georgia seized by Philadelphia CPB officers, officials say13 May 2026 Officers with U.S. Customs and Border Protection say they seized tens of thousands of potentially dangerous pills that…
MMedication Read More New pill sees people lose fifth of body weight in major study13 May 2026 The tablet is not yet available in the UK but was approved in the US in DecemberNeil Shaw…
MMedication Read More RJK Jr’s anti-SSRI campaign is long overdue13 May 2026 Health Secretary Robert F. Kennedy Jr’s questions this week about the scale of antidepressant use in the United…
MMedication Read More GLP-1s like Ozempic masked our cancer symptoms13 May 2026 Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…